Shopping Cart
- Remove All
Your shopping cart is currently empty
PFI-3 is a selective chemical inhibitor for SMARCA (2/4) (Kd = 89 nM)and PBI (5) bromodomains which may result in the delay and prevention of breast cancer.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $32 | In Stock | |
| 2 mg | $45 | In Stock | |
| 5 mg | $71 | In Stock | |
| 10 mg | $105 | In Stock | |
| 25 mg | $220 | In Stock | |
| 50 mg | $335 | In Stock | |
| 100 mg | $498 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $71 | In Stock |
| Description | PFI-3 is a selective chemical inhibitor for SMARCA (2/4) (Kd = 89 nM)and PBI (5) bromodomains which may result in the delay and prevention of breast cancer. |
| Targets&IC50 | SMARCA4:55 nM(Kd), SMARCA2A:110 nM(Kd), SMARCA2B:72 nM(Kd) |
| In vitro | PFI-3 shows a significant selectivity for PB1(5) and SMARCA2/4 over 36 other tested kinases. [1] |
| Synonyms | PFI 3 |
| Molecular Weight | 321.37 |
| Formula | C19H19N3O2 |
| Cas No. | 1819363-80-8 |
| Smiles | [H][C@@]12CN(c3ccccn3)[C@@]([H])(CN1\C=C\C(=O)c1ccccc1O)C2 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 32.1 mg/mL (99.88 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.